Shoreline Biome to launch new DNA isolation kit at Miami Winter Symposium 2020

Kit isolates high molecular weight single-stranded DNA efficiently, without bias

January 24, 2020

FARMINGTON, Conn.— Shoreline Biome, a microbiome research company based here that develops tools for characterizing microbiome populations down to the strain level, will announce a novel new DNA isolation kit at the Miami Winter Symposium 2020.

The new product, Shoreline Biome’s Rapid Prep kit, is a fast and easy-to-use kit designed for the efficient and unbiased isolation of high molecular weight (HMW) single-stranded DNA (ssDNA) in excess of 40KB from Gram-negative and Gram-positive bacterial and fungal cultures. The ssDNA output is ideal for downstream PCR applications targeting specific microbial, fungal, or mammalian genes of interest. 

In addition, the company will present a poster in collaboration with researchers from West Virginia University School of Medicine.

Shoreline Biome’s poster presentation, titled “Sustained Gut Dysbiosis Following Experimental Sepsis in Alzheimer’s Disease Transgenic Mice,” is scheduled for Monday, January 27, from 1:30–2:30 p.m. The poster presents research conducted by Allison L. Brichacek, Divine C. Nwafor, Dawn Gratalo, Mark D. Driscoll, and Candice M. Brown. The session will be presented by Brichacek, a student in Brown’s lab at West Virginia University School of Medicine.

Shoreline Biome will also be an exhibitor at the symposium.

The Miami Winter Symposium 2020 will be held January 26–29, 2020, at the Hyatt Regency Miami in Miami, Fla. The symposium is dedicated to molecular mechanisms linking the microbiome and human health. It includes an international line-up of renowned speakers; award lectures by the “stars” of microbiome research; focused sessions on hot topics in microbiome research; the latest international research; and networking opportunities with key research teams from around the world. For more information about the Miami Winter Symposium 2020, visit miamiwintersymposium.com.

Characterizing the human microbiome and analyzing its role in human health and disease are priority goals for researchers around the world. Shoreline Biome accelerates breakthroughs in microbiome research by developing transformative discovery tools that characterize microbiome populations down to the strain level. With Shoreline Biome products, all it takes is three easy steps: lyse, purify, and amplify. Shoreline Biome’s easy-to-use companion analysis software and comprehensive reference database enables straightforward strain-level identification and quantitation of all bacteria in the sample. To learn more, visit shorelinebiome.com.

For more information contact:

Shoreline Biome
Bill McKenzie, CEO
617-817-0929
Bill.McKenzie@ShorelineBiome.com